# EDGAR Filing Document

**Accession Number:** 0001974915
**File Stem:** 0001974915-25-000008
**Filing Date:** 2025-11
**Character Count:** 11926
**Document Hash:** 5a427b10ff0bae9a1a06b838226eeaec
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001974915-25-000008.hdr.sgml**: 20251114

**ACCESSION NUMBER**: 0001974915-25-000008

**CONFORMED SUBMISSION TYPE**: 13F-HR

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251114

**DATE AS OF CHANGE**: 20251114

**EFFECTIVENESS DATE**: 20251114

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Vestal Point Capital, LP
- **CENTRAL INDEX KEY:** 0001974915

**ORGANIZATION NAME:**
- **EIN:** 922296021
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 13F-HR
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-23784
- **FILM NUMBER:** 251485599

**BUSINESS ADDRESS:**
- **STREET 1:** 632 BROADWAY
- **STREET 2:** SUITE 602
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10012
- **BUSINESS PHONE:** 6469894000

**MAIL ADDRESS:**
- **STREET 1:** 632 BROADWAY
- **STREET 2:** SUITE 602
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10012

### FORM 13F COVER PAGE

**Report for the Calendar Year or Quarter Ended:** 09-30-2025

**Check here if Amendment** [ ] **Amendment Number:** 

**This Amendment (Check only one.):** [ ] is a restatement.

[ ] adds new holdings entries.

**Institutional Investment Manager Filing this Report:**

**Name:** Vestal Point Capital LP<br>**Address:** 632 BROADWAY<br>SUITE 602<br>NEW YORK, NY 10012

**Form 13F File Number:** 028-23784

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

**Person Signing this Report on Behalf of Reporting Manager:**

**Name:** Ilko Menkov<br>**Title:** Partner COO and CCO<br>**Phone:** 6469894002

**Signature, Place, and Date of Signing:**

Ilko Menkov  New York, NY  11-14-2025<br>[Signature]  [City, State]  [Date]

**Report Type (Check only one.):**

[x] **13F HOLDINGS REPORT.** (Check here if all holdings of this reporting manager are reported in this report.)

[ ] **13F NOTICE.** (Check here if no holdings are reported in this report, and all holdings are reported by other reporting manager(s).)

[ ] **13F COMBINATION REPORT.** (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)

### Form 13F Summary Page

**Report Summary:**

**Number of Other Included Managers:** 0

**Form 13F Information Table Entry Total:** 81

**Form 13F Information Table Value Total:** $2214439953

      (round to nearest dollar)

**List of Other Included Managers:**

Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.

[If there are no entries in this list, state “NONE” and omit the column headings and list entries.]

**NONE**

### FORM 13F INFORMATION TABLE

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | VALUE (x$1000) | SHRS OR PRN AMT | SH/PRN | PUT/CALL | INVESTMENT DISCRETION | OTHER MANAGER | VOTING AUTHORITY | VOTING AUTHORITY | VOTING AUTHORITY |
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | VALUE (x$1000) | SHRS OR PRN AMT | SH/PRN | PUT/CALL | INVESTMENT DISCRETION | OTHER MANAGER | SOLE | SHARED | NONE |
| Abbott Laboratories | COM | 002824100 |  | 33485000 | 250000 | SH |  | SOLE |  | 250000 | 0 | 0 |
| Abivax SA | SPONSORED ADS | 00370M103 |  | 84900000 | 1000000 | SH |  | SOLE |  | 1000000 | 0 | 0 |
| Agios Pharmaceuticals Inc | COM | 00847X104 |  | 5097780 | 127000 | SH |  | SOLE |  | 127000 | 0 | 0 |
| Alcon AG | ORD SHS | H01301128 |  | 81961000 | 1100000 | SH |  | SOLE |  | 1100000 | 0 | 0 |
| Alector Inc | COM | 014442107 |  | 2900800 | 980000 | SH |  | SOLE |  | 980000 | 0 | 0 |
| Alto Neuroscience Inc | COM SHS | 02157Q109 |  | 3819000 | 950000 | SH |  | SOLE |  | 950000 | 0 | 0 |
| Amicus Therapeutics Inc | COM | 03152W109 |  | 76830000 | 9750000 | SH |  | SOLE |  | 9750000 | 0 | 0 |
| Apogee Therapeutics Inc | COM | 03770N101 |  | 16885250 | 425000 | SH |  | SOLE |  | 425000 | 0 | 0 |
| Applied Therapeutics Inc | COM | 03828A101 |  | 8619825 | 14250000 | SH |  | SOLE |  | 14250000 | 0 | 0 |
| Arcellx Inc | COMMON STOCK | 03940C100 |  | 102625000 | 1250000 | SH |  | SOLE |  | 1250000 | 0 | 0 |
| Arcus Biosciences Inc | COM | 03969F109 |  | 3400000 | 250000 | SH |  | SOLE |  | 250000 | 0 | 0 |
| Arcutis Biotherapeutics Inc | COM | 03969K108 |  | 3770000 | 200000 | SH |  | SOLE |  | 200000 | 0 | 0 |
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 |  | 119286000 | 600000 | SH |  | SOLE |  | 600000 | 0 | 0 |
| Astria Therapeutics Inc | COM | 04635X102 |  | 36079680 | 4956000 | SH |  | SOLE |  | 4956000 | 0 | 0 |
| Axsome Therapeutics Inc | COM | 05464T104 |  | 18217500 | 150000 | SH |  | SOLE |  | 150000 | 0 | 0 |
| Becton Dickinson  Co | COM | 075887109 |  | 60830250 | 325000 | SH |  | SOLE |  | 325000 | 0 | 0 |
| Belite Bio Inc | SPONSORED ADS | 07782B104 |  | 23125000 | 312500 | SH |  | SOLE |  | 312500 | 0 | 0 |
| Beta Bionics Inc | COM | 08659B102 |  | 11922000 | 600000 | SH |  | SOLE |  | 600000 | 0 | 0 |
| Bicara Therapeutics Inc | COM | 055477103 |  | 80529000 | 5100000 | SH |  | SOLE |  | 5100000 | 0 | 0 |
| Biogen Inc | COM | 09062X103 |  | 38522000 | 275000 | SH |  | SOLE |  | 275000 | 0 | 0 |
| Biohaven Ltd | COM | G1110E107 |  | 10532517 | 701700 | SH | Put | SOLE |  | 701700 | 0 | 0 |
| BioMarin Pharmaceutical Inc | COM | 09061G101 |  | 44952800 | 830000 | SH |  | SOLE |  | 830000 | 0 | 0 |
| Black Diamond Therapeutics Inc | COM | 09203E105 |  | 21034500 | 5550000 | SH |  | SOLE |  | 5550000 | 0 | 0 |
| Bruker Corp | COM | 116794108 |  | 14295600 | 440000 | SH |  | SOLE |  | 440000 | 0 | 0 |
| Celldex Therapeutics Inc | COM NEW | 15117B202 |  | 31173350 | 1205000 | SH |  | SOLE |  | 1205000 | 0 | 0 |
| CG Oncology Inc | COM | 156944100 |  | 7049000 | 175000 | SH |  | SOLE |  | 175000 | 0 | 0 |
| Cidara Therapeutics Inc | COM NEW | 171757206 |  | 38304000 | 400000 | SH |  | SOLE |  | 400000 | 0 | 0 |
| Crinetics Pharmaceuticals Inc | COM | 22663K107 |  | 31237500 | 750000 | SH |  | SOLE |  | 750000 | 0 | 0 |
| Cytokinetics Inc | COM NEW | 23282W605 |  | 39846000 | 725000 | SH |  | SOLE |  | 725000 | 0 | 0 |
| Danaher Corp | COM | 235851102 |  | 29739000 | 150000 | SH |  | SOLE |  | 150000 | 0 | 0 |
| Day One Biopharmaceuticals Inc | COM | 23954D109 |  | 18858750 | 2675000 | SH |  | SOLE |  | 2675000 | 0 | 0 |
| Dexcom Inc | COM | 252131107 |  | 43738500 | 650000 | SH |  | SOLE |  | 650000 | 0 | 0 |
| Dianthus Therapeutics Inc | COM | 252828108 |  | 46433000 | 1180000 | SH |  | SOLE |  | 1180000 | 0 | 0 |
| Disc Medicine Inc | COM | 254604101 |  | 33040000 | 500000 | SH |  | SOLE |  | 500000 | 0 | 0 |
| Dyne Therapeutics Inc | COM | 26818M108 |  | 35103750 | 2775000 | SH |  | SOLE |  | 2775000 | 0 | 0 |
| Engene Holdings Inc | COM | 29286M105 |  | 2527100 | 370000 | SH |  | SOLE |  | 370000 | 0 | 0 |
| Enliven Therapeutics Inc | COM | 29337E102 |  | 23745200 | 1160000 | SH |  | SOLE |  | 1160000 | 0 | 0 |
| Establishment Labs Holdings In | COM | G31249108 |  | 4099000 | 100000 | SH |  | SOLE |  | 100000 | 0 | 0 |
| Exact Sciences Corp | COM | 30063P105 |  | 4103250 | 75000 | SH |  | SOLE |  | 75000 | 0 | 0 |
| Fate Therapeutics Inc | COM | 31189P102 |  | 3168900 | 2515000 | SH |  | SOLE |  | 2515000 | 0 | 0 |
| Geron Corp | COM | 374163103 |  | 23598250 | 17225000 | SH |  | SOLE |  | 17225000 | 0 | 0 |
| Globus Medical Inc | CL A | 379577208 |  | 71587500 | 1250000 | SH |  | SOLE |  | 1250000 | 0 | 0 |
| GSK PLC | SPONSORED ADR | 37733W204 |  | 5395000 | 125000 | SH |  | SOLE |  | 125000 | 0 | 0 |
| Immatics NV | SHS | N44445109 |  | 54102000 | 6350000 | SH |  | SOLE |  | 6350000 | 0 | 0 |
| Inspire Medical Systems Inc | COM | 457730109 |  | 10017000 | 135000 | SH |  | SOLE |  | 135000 | 0 | 0 |
| Ionis Pharmaceuticals Inc | COM | 462222100 |  | 70326500 | 1075000 | SH |  | SOLE |  | 1075000 | 0 | 0 |
| Jazz Pharmaceuticals PLC | SHS USD | G50871105 |  | 65900000 | 500000 | SH |  | SOLE |  | 500000 | 0 | 0 |
| KalVista Pharmaceuticals Inc | COM | 483497103 |  | 9135000 | 750000 | SH |  | SOLE |  | 750000 | 0 | 0 |
| Kodiak Sciences Inc | COM | 50015M109 |  | 4092500 | 250000 | SH |  | SOLE |  | 250000 | 0 | 0 |
| Lantheus Holdings Inc | COM | 516544103 |  | 8719300 | 170000 | SH |  | SOLE |  | 170000 | 0 | 0 |
| Lexeo Therapeutics Inc | COM | 52886X107 |  | 21580000 | 3250000 | SH |  | SOLE |  | 3250000 | 0 | 0 |
| MacroGenics Inc | COM | 556099109 |  | 470400 | 280000 | SH |  | SOLE |  | 280000 | 0 | 0 |
| Monte Rosa Therapeutics Inc | COM | 61225M102 |  | 5928000 | 800000 | SH |  | SOLE |  | 800000 | 0 | 0 |
| Myriad Genetics Inc | COM | 62855J104 |  | 4338000 | 600000 | SH |  | SOLE |  | 600000 | 0 | 0 |
| Novocure Ltd | ORD SHS | G6674U108 |  | 5168000 | 400000 | SH |  | SOLE |  | 400000 | 0 | 0 |
| Nurix Therapeutics Inc | COM | 67080M103 |  | 32109000 | 3475000 | SH |  | SOLE |  | 3475000 | 0 | 0 |
| Nuvalent Inc | COM | 670703107 |  | 95128000 | 1100000 | SH |  | SOLE |  | 1100000 | 0 | 0 |
| Nyxoah SA | SHS | B6S7WD106 |  | 5094100 | 1107413 | SH |  | SOLE |  | 1107413 | 0 | 0 |
| OnKure Therapeutics Inc | COM CL A | 68277Q105 |  | 1746250 | 635000 | SH |  | SOLE |  | 635000 | 0 | 0 |
| Passage Bio Inc | COM NEW | 702712209 |  | 2449150 | 305000 | SH |  | SOLE |  | 305000 | 0 | 0 |
| Pulmonx Corp | COM | 745848101 |  | 1344600 | 830000 | SH |  | SOLE |  | 830000 | 0 | 0 |
| Rapport Therapeutics Inc | COM | 75383L102 |  | 28215000 | 950000 | SH |  | SOLE |  | 950000 | 0 | 0 |
| Regeneron Pharmaceuticals Inc | COM | 75886F107 |  | 14056750 | 25000 | SH |  | SOLE |  | 25000 | 0 | 0 |
| Repligen Corp | COM | 759916109 |  | 53468000 | 400000 | SH |  | SOLE |  | 400000 | 0 | 0 |
| Revolution Medicines Inc | COM | 76155X100 |  | 29421000 | 630000 | SH |  | SOLE |  | 630000 | 0 | 0 |
| Savara Inc | COM | 805111101 |  | 14333550 | 4015000 | SH |  | SOLE |  | 4015000 | 0 | 0 |
| Scholar Rock Holding Corp | COM | 80706P103 |  | 55860000 | 1500000 | SH |  | SOLE |  | 1500000 | 0 | 0 |
| Solid Biosciences Inc | COM NEW | 83422E204 |  | 18355750 | 2975000 | SH |  | SOLE |  | 2975000 | 0 | 0 |
| Sutro Biopharma Inc | COM | 869367102 |  | 2257840 | 2600000 | SH |  | SOLE |  | 2600000 | 0 | 0 |
| Taysha Gene Therapies Inc | COM SHS | 877619106 |  | 17985000 | 5500000 | SH |  | SOLE |  | 5500000 | 0 | 0 |
| Tenax Therapeutics Inc | COM NEW | 88032L605 |  | 406671 | 53439 | SH |  | SOLE |  | 53439 | 0 | 0 |
| Traws Pharma Inc | COM NEW | 68232V884 |  | 277500 | 150000 | SH |  | SOLE |  | 150000 | 0 | 0 |
| Tvardi Therapeutics Inc | COM | 140755307 |  | 6507990 | 167000 | SH |  | SOLE |  | 167000 | 0 | 0 |
| Tyra Biosciences Inc | COM | 90240B106 |  | 33925750 | 2425000 | SH |  | SOLE |  | 2425000 | 0 | 0 |
| Ultragenyx Pharmaceutical Inc | COM | 90400D108 |  | 22560000 | 750000 | SH |  | SOLE |  | 750000 | 0 | 0 |
| uniQure NV | SHS | N90064101 |  | 13133250 | 225000 | SH |  | SOLE |  | 225000 | 0 | 0 |
| Ventyx Biosciences Inc | COM | 92332V107 |  | 6375500 | 2050000 | SH |  | SOLE |  | 2050000 | 0 | 0 |
| Vera Therapeutics Inc | CL A | 92337R101 |  | 22085600 | 760000 | SH |  | SOLE |  | 760000 | 0 | 0 |
| Voyager Therapeutics Inc | COM | 92915B106 |  | 6888250 | 1475000 | SH |  | SOLE |  | 1475000 | 0 | 0 |
| Xenon Pharmaceuticals Inc | COM | 98420N105 |  | 44165000 | 1100000 | SH |  | SOLE |  | 1100000 | 0 | 0 |
| Zymeworks Inc | COM | 98985Y108 |  | 30146200 | 1765000 | SH |  | SOLE |  | 1765000 | 0 | 0 |

---